Nov 18, 2024  |  4:00pm - 5:00pm

Preserving what we have: understanding formation and maintenance of ovarian reserve

Type
Monday seminar series
Tag(s)
Disruptive Innovation, Impactful research

As part of our Monday seminar series, we are delighted to welcome our speaker:

Talk title: Preserving what we have; understanding formation and maintenance of ovarian reserve.

Dr. Andrea Jurisicova PhD
Senior Investigator, Lunenfeld Tanenbaum Research Institute
Associate Professor, Department of Obstetrics & Gynaecology, University of Toronto

Hosted By

Saudah Butt, MHSc

How to join

The event will be in person only, no need to register.

MSB 2172

Medical Sciences Building
University of Toronto
1 King’s College Circle
Toronto, ON  M5S 1A8 

If you have any questions about this event, please contact Debb Yorke at lmp.chairadmin@utoronto.ca.

Speaker: Dr. Andrea Jurisicova

Andrea obtained her BSc degree from Comenius University, Bratislava, Slovakia in the field of Genetics and Molecular biology. During the last two years of her studies she also worked as a clinical embryologist in the IVF clinic. This exposure to clinical environment prompted her interest in high rate of embryo demise and low implantation rate in infertile patients. Upon her move to Canada, she completed the MSc degree in Reproductive Physiology (1993), followed by PhD (1998) in Developmental biology, both at University of Toronto. During her postdoctoral training, completed at Massachusetts General Hospital/Harvard Medical School, she focused her attention on the regulation of cell death in the female gonad, with particular interest in germ cells. She is currently an Associate Professor at the Departments of Ob&Gyn and Physiology at University of Toronto, as well as Senior Investigator at Lunenfeld Tanenbaum Research Institute at Sinai Health Systems. Jurisicova’s laboratory focuses on molecular and cellular analysis of female germline, studying how oocyte quality and quantity impacts reproductive lifespan and early embryo development.  We are interested in genetic modifications causing premature ovarian failure in human, which we follow up with studies of functional consequences in animal models.

Andrea Jurisicova